Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,026,500 | 1,045,000 | 930,900 | 909,700 | 859,100 |
| Cost of Goods | 90,600 | 95,300 | 91,600 | 144,600 | 157,000 |
| Gross Profit | 935,900 | 949,700 | 839,300 | 765,100 | 702,100 |
| Operating Expenses | 577,900 | 1,350,100 | 572,500 | 657,100 | 622,000 |
| Operating Income | 358,600 | -400,100 | 267,400 | 108,600 | 80,100 |
| Interest Expense | 24,600 | 25,000 | 24,100 | 25,100 | 25,000 |
| Other Income | 8,100 | 6,500 | 108,300 | 5,800 | 3,100 |
| Pre-tax Income | 342,100 | -418,600 | 351,600 | 89,300 | 58,200 |
| Income Tax | 11,200 | 38,800 | 102,500 | 59,300 | -19,800 |
| Net Income Continuous | 330,900 | -457,400 | 249,100 | 30,000 | 78,000 |
| Net Income | $330,900 | $-457,400 | $249,100 | $30,000 | $78,000 |
| EPS Basic Total Ops | 1.48 | -2.05 | 1.12 | 0.13 | 0.35 |
| EPS Basic Continuous Ops | 1.48 | -2.05 | 1.12 | 0.14 | 0.35 |
| EPS Diluted Total Ops | 1.47 | -2.05 | 1.11 | 0.14 | 0.35 |
| EPS Diluted Continuous Ops | 1.47 | -2.05 | 1.11 | 0.14 | 0.35 |
| EBITDA(a) | $463,500 | $-299,600 | $368,900 | $293,700 | $159,500 |